Cite
Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
MLA
Carlijn C E Jordans, et al. “Interferon-Α2 Auto-Antibodies in Convalescent Plasma Therapy for COVID-19.” Journal of Clinical Immunology, vol. 42, Nov. 2021, pp. 232–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....308fe8b2789fa7c2fb05370d1f81ce57&authtype=sso&custid=ns315887.
APA
Carlijn C E Jordans, Anna Z Mykytyn, Eric C. M. van Gorp, Mart M. Lamers, Corine H. GeurtsvanKessel, Matthijs P. Raadsen, Arvind Gharbharan, Bart J. A. Rijnders, Bart L. Haagmans, Johannes P. C. van den Akker, Petra B. van den Doel, Henrik Endeman, Marco Goeijenbier, Marion Koopmans, & Casper Rokx. (2021). Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19. Journal of Clinical Immunology, 42, 232–239.
Chicago
Carlijn C E Jordans, Anna Z Mykytyn, Eric C. M. van Gorp, Mart M. Lamers, Corine H. GeurtsvanKessel, Matthijs P. Raadsen, Arvind Gharbharan, et al. 2021. “Interferon-Α2 Auto-Antibodies in Convalescent Plasma Therapy for COVID-19.” Journal of Clinical Immunology 42 (November): 232–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....308fe8b2789fa7c2fb05370d1f81ce57&authtype=sso&custid=ns315887.